1105039-92-6

Basic information

• Product Name: ethyl 1-[(4-methoxyphenyl)methyl]-3-(trifluoromethyl)pyrazole-4-carboxylate
• Synonyms: ethyl 1-[(4-methoxyphenyl)methyl]-3-(trifluoromethyl)pyrazole-4-carboxylate
• CAS NO: 1105039-92-6
• Molecular Weight: 328.291
• Mol File: 1105039-92-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: ethyl 1-[(4-methoxyphenyl)methyl]-3-(trifluoromethyl)pyrazole-4-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 1-[(4-methoxyphenyl)methyl]-3-(trifluoromethyl)pyrazole-4-carboxylate(1105039-92-6)
• EPA Substance Registry System: ethyl 1-[(4-methoxyphenyl)methyl]-3-(trifluoromethyl)pyrazole-4-carboxylate(1105039-92-6)

Safety Data

• Hazardous Substances Data: 1105039-92-6(Hazardous Substances Data)

Upstream product

• 824-94-2 p-methoxybenzyl chloride 
• 155377-19-8 ethyl 3-trifluoromethyl-1H-pyrazole-4-carboxylate 
• 155377-19-8 ethyl 5-(trifluoromethyl)-1H-pyrazole-4-carboxylate 
• 2746-25-0 p-Methoxybenzyl bromide 

Downstream Products

• 1105039-51-7 1-[(4-methoxyphenyl)methyl]-3-(trifluoromethyl)pyrazole-4-carboxylic acid 
• 1525641-12-6 [3-(trifluoromethyl)-1H-pyrazol-4-yl]methanamine 
• 1262848-94-1 1-(4-methoxybenzyl)-3-(trifluoromethyl)-1H-pyrazole-4-carboximidamide 
• 1262848-97-4 3-(1-(4-methoxybenzyl)-3-(trifluoromethyl)-1H-pyrazol-4-yl)-5-(pyridin-2-yloxy)-1,2,4-thiadiazole 
• 1262848-95-2 5-chloro-3-(1-(4-methoxybenzyl)-3-(trifluoromethyl)-1H-pyrazol-4-yl)-1,2,4-thiadiazole 
• 1105039-50-6 1-(4-methoxybenzyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid 

Relevant articles and documents

ARYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION

The present invention relates to novel compounds of formula (I), wherein R1, R2, R3, R4, R5 and R6 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds as DNA gyrase and/or topoisomerase IV inhibitors in the treatment and/or prophylaxis of bacterial infection.

Novel Pyrazole Derivatives and their use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors

The present invention relates to novel compounds of Formula (I), wherein M, P, X1, (A)m and (B)n are defined as in Formula (I); invention compounds are modulators of metabotropic glutamate receptors—subtype 4 (“mGluR4”) wh

TETRASUBSTITUTED PYRIDAZINE HEDGEHOG PATHWAY ANTAGONISTS

The present invention provides novel tetrasubstituted pyridine hedgehog pathway antagonists of the following formula I (I) or a pharmaceutically acceptable salt thereof, wherein: X is C-R1 or N; R1 is hydrogen, fluoro or cyano; Rsup